Markos Leggas

3.2k citations
79 papers · 2.5k indexed · h-index 24

Impact in

  • Oncology top 2%
    • Drug Transport and Resistance Mechanisms
    • Nanoparticle-Based Drug Delivery

Papers in

    • Drug Transport and Resistance Mechanisms 16
    • Lung Cancer Research Studies 10

Markos Leggas

73 papers receiving 2.4k citations

Peers

Markos Leggas
Comparison fields: 5 of 132
  • Oncology 1.1k
  • Biomaterials 300
  • Pharmaceutical Science 137
  • Pediatrics, Perinatology and Child Health 349
  • Pharmacology 153
Replace J. Fred Nagelkerke with:
J. Fred Nagelkerke Netherlands
Akinobu Hamada Japan
Scott J. Weir United States
Annarica Calcabrini Italy
William N. Hait United States
Rajesh Krishna United States
Hirotami Matsuo Japan
Albert Breier Slovakia
Ryungsa Kim Japan
Antonio Pineda‐Lucena Spain
Markos Leggas relative to J. Fred Nagelkerke Netherlands J. Fred Nagelkerke's profile →
Citations per field
00.5×3.9×
J. Fred Nagelkerke · 1×
Citations per year

Countries citing papers authored by Markos Leggas

Since Specialization
Citations

This map shows the geographic impact of Markos Leggas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markos Leggas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markos Leggas more than expected).

Fields of papers citing papers by Markos Leggas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markos Leggas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markos Leggas. The network helps show where Markos Leggas may publish in the future.

Co-authors

The 25 scholars most cited alongside Markos Leggas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markos Leggas Line = papers co-authored together Markos Leggas links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 202113
3 201516
4 201411
5 2013204
6 201324
7 201213
8 20127
9 201212
10 20125
11 201023
12 20108
13 201010
14 2009137
15 200826
16 200815
17 200773
18 2007157
19 200615
20 2004321

About Markos Leggas

Markos Leggas is a scholar working on Oncology, Aging, Endocrine and Autonomic Systems, Pharmacology and Cancer Research, having authored 79 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (23 papers), Drug Transport and Resistance Mechanisms (16 papers), Lung Cancer Research Studies (10 papers), Nanoparticle-Based Drug Delivery (8 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Prenatal Substance Exposure Effects (7 papers), Cancer, Lipids, and Metabolism (6 papers) and Neuroscience of respiration and sleep (6 papers). The work is most often cited by research in Oncology (1.1k citations), Biomaterials (300 citations), Pharmaceutical Science (137 citations), Pediatrics, Perinatology and Child Health (349 citations) and Pharmacology (153 citations). Markos Leggas has collaborated with scholars based in United States, Netherlands and Czechia. Frequent co-authors include Val R. Adams, John D. Schuetz, Clinton F. Stewart, John C. Panetta, B. Mark Evers, Daxi Sun, Masashi Adachi, Yanli Zhuang, Brad Johnston and George L. Scheffer. Their work appears in journals such as Cancer Research, Drug Metabolism and Disposition, Journal of Clinical Oncology, Biomedical Chromatography and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026